Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden
Hydroxyurea added to chronic transfusion therapy for patients with SCA is feasible and decreases RBC transfusion volume requirements.
Authors
- Robert Sheppard Nickel (ORCID: https://orcid.org/0000-0003-4277-7523)
- James E. Bost
- Gustavo Niño (ORCID: https://orcid.org/0000-0001-8621-6109)
- Stefanie Margulies
- Jennifer Webb (ORCID: https://orcid.org/0000-0003-1463-4963)
- Marcin Gierdalski (ORCID: https://orcid.org/0000-0002-4429-7825)
- Elizabeth Chorvinsky
- Karuna Panchapakesan
- Naomi L.C. Luban
Institutions
- Children's National (US)
- George Washington University (US)
- National Research Institute (US)
Publication Details
- Journal
- Transfusion
- Published
- 2024-11-24
- DOI
- https://doi.org/10.1111/trf.18073
- Citations
- 3
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- Children's National Hospital
- National Institutes of Health
- National Blood Foundation
- National Center for Advancing Translational Sciences